Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol., 10 February 2026

Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers

Volume 16 - 2026 | https://doi.org/10.3389/fonc.2026.1798299

Correction: Long-term survival of an advanced gastric cancer patient with multiple liver metastases following maintenance therapy with envafolimab and oral chemotherapy: a case report

This article is a correction to:

  1. Long-term survival of an advanced gastric cancer patient with multiple liver metastases following maintenance therapy with envafolimab and oral chemotherapy: a case report

    1. Read original article
Frontiers Production Office* Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

A Correction on
Long-term survival of an advanced gastric cancer patient with multiple liver metastases following maintenance therapy with envafolimab and oral chemotherapy: a case report

By Wang S, Zong H, Wu L, Wei Y and Wang H (2025) Front. Oncol. 15:1685259. doi: 10.3389/fonc.2025.1685259

Affiliation “Zist Balin Co. Iran”, was erroneously given as “Sodour Ahrar Shargh Co., Iran”.

The original version of this article has been updated.

Keywords: advanced gastric cancer, liver metastases, immunotherapy, envafolimab, raltitrexed, maintenance therapy, long-term survival

Citation: Frontiers Production Office (2026) Correction: Long-term survival of an advanced gastric cancer patient with multiple liver metastases following maintenance therapy with envafolimab and oral chemotherapy: a case report. Front. Oncol. 16:1798299. doi: 10.3389/fonc.2026.1798299

Received: 28 January 2026; Accepted: 28 January 2026;
Published: 10 February 2026.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2026 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.